17 Sep 2008 BT Pharma successfully closes EUR 2.8 million (USD 4M) financing round
10 Sep 2008 ImVisioN Therapeutics Starts Phase I Clinical Trial of IVN201 Against Cat Dander Allergy and Raises CHF 4.6 M
10 Sep 2008 New Phase II data show Novartis investigational Meningitis B vaccine may also protect infants six months and older
10 Sep 2008 Circassia Achieves Successful Phase II Clinical Results With ToleroMune(R) Anti-Allergy Technology
03 Sep 2008 Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program
03 Sep 2008 Phase III U.S. Pivotal Study Results on CSL Biotherapies' Afluria Published in Vaccine
28 Aug 2008 Intercell announces initiation of further Phase II clinical trial of V710 an investigational vaccine
28 Aug 2008 Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
27 Aug 2008 Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer
26 Aug 2008 Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
21 Aug 2008 NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
21 Aug 2008 VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study
21 Aug 2008 VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study
20 Aug 2008 BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
19 Aug 2008 EndoBiologics, Incorporated, and PATH Form New Collaboration to Research Vaccine Candidates Against Diarrheal Disease
16 Aug 2008 Cytos Biotechnology and Pfizer enter into a research, option and license agreement for certain novel vaccines for a defined number of human diseases
14 Aug 2008 Bioms Medical Announces Positive Interim Analysis on Phase III Trial of Dirucotide (MBP8298) For Multiple Sclerosis
07 Aug 2008 DOR BioPharma Announces Initiation of Second Human Clinical Trial for RiVax(TM), Its Ricin Toxin Vaccine
06 Aug 2008 Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV(TM)) Met its Primary Endpoint
05 Aug 2008 Bionor Immuno have started a Vacc-4x Phase IIB TOC study in US and Europe with enrollment of 345 patients.
03 Aug 2008 Bioms Medical Completes Patient Recruitment in Phase III U.S. Multiple Sclerosis Trial
28 Jul 2008 Nventa Announces Final Data From HSPE7 Phase I Cervical Dysplasia Trial
23 Jul 2008 Nabi Biopharmaceuticals Announces Positive Interim Results of NicVAX Immunogenicity Study
22 Jul 2008 Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin(R) for Multiple Sclerosis
18 Jul 2008 Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID(R) Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up